GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Thelma Therapeutics (XKRX:015540) » Definitions » Deferred Tax

Thelma Therapeutics (XKRX:015540) Deferred Tax : ₩0 Mil (TTM As of Sep. 2022)


View and export this data going back to 1989. Start your Free Trial

What is Thelma Therapeutics Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Thelma Therapeutics's change in deferred tax for the three months ended in Sep. 2022 was ₩0 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Sep. 2022 was ₩0 Mil.

Thelma Therapeutics Deferred Tax Historical Data

The historical data trend for Thelma Therapeutics's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thelma Therapeutics Deferred Tax Chart

Thelma Therapeutics Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.94 4.90 - - -

Thelma Therapeutics Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Thelma Therapeutics Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thelma Therapeutics Deferred Tax Related Terms

Thank you for viewing the detailed overview of Thelma Therapeutics's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Thelma Therapeutics (XKRX:015540) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Thelma Therapeutics (XKRX:015540) » Definitions » Deferred Tax
Comparable Companies
XKRX:058850 XKRX:052600 XKRX:067730 XKRX:068940 XKRX:021650 XKRX:049720 XKRX:020710 XKRX:115570 XKRX:204620 XKRX:260930 TSX:TRI CTAS GPN XAMS:WKL XPAR:TEP LSE:RTO ASX:BXB XPAR:SW LSE:ITRK ARMK
Traded in Other Exchanges
N/A
Address
Mapo-gu, Seoul Sangam DMC Prugio City, 25, World Cup Buk-ro 54-gil, Seoul, KOR
Website
http://www.medi-plant.co.kr
Thelma Therapeutics, formerly Medipartner Biotechnology is a South Korean company engaged in providing hospital management support, dental material distribution, medical devices manufacturing, and development of new materials.

Thelma Therapeutics (XKRX:015540) Headlines

No Headlines